Savara Inc - Common Stock, par value $0.001 per share (SVRA)
CUSIP: 805111101
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 210,922,101
- Total 13F shares
- 89,090,177
- Share change
- +5,565,543
- Total reported value
- $284,756,437
- Put/Call ratio
- 0%
- Price per share
- $3.20
- Number of holders
- 76
- Value change
- +$19,803,798
- Number of buys
- 45
- Number of sells
- 36
Quarterly Holders Quick Answers
What is CUSIP 805111101?
CUSIP 805111101 identifies SVRA - Savara Inc - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 805111101:
Top shareholders of SVRA - Savara Inc - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| NEA Management Company, LLC |
13F
|
Company |
11%
|
24,137,931
|
$47,068,965 | — | 31 Mar 2023 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
5.5%
|
11,622,598
|
$22,664,000 | — | 31 Mar 2023 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
5.2%
|
10,908,086
|
$21,270,768 | — | 31 Mar 2023 | |
| CAXTON CORP |
13F
|
Company |
3.3%
|
6,896,551
|
$13,448,274 | — | 31 Mar 2023 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
3.3%
|
6,864,551
|
$13,385,874 | — | 31 Mar 2023 | |
| VR Adviser, LLC |
13F
|
Company |
3%
|
6,351,531
|
$12,385,485 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.2%
|
4,726,673
|
$9,217,012 | — | 31 Mar 2023 | |
| AXA S.A. |
13F
|
Company |
1.3%
|
2,829,330
|
$5,517,194 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.51%
|
1,072,353
|
$2,091,088 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.5%
|
1,044,378
|
$2,036,537 | — | 31 Mar 2023 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.45%
|
948,457
|
$1,849,491 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.41%
|
859,418
|
$1,676,000 | — | 31 Mar 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.33%
|
700,159
|
$1,365,310 | — | 31 Mar 2023 | |
| Badrul A. Chowdhury |
3/4/5
|
CHIEF MEDICAL OFFICER |
—
mixed-class rows
|
400,000
mixed-class rows
|
$1,335,000 | — | 14 Dec 2021 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.26%
|
556,513
|
$1,085,200 | — | 31 Mar 2023 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.18%
|
386,793
|
$754,246 | — | 31 Mar 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.13%
|
282,345
|
$550,573 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.13%
|
268,011
|
$522,621 | — | 31 Mar 2023 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.1%
|
207,646
|
$404,910 | — | 31 Mar 2023 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.09%
|
199,031
|
$388,110 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.09%
|
192,926
|
$376,206 | — | 31 Mar 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.09%
|
186,856
|
$364,369 | — | 31 Mar 2023 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.09%
|
183,880
|
$358,566 | — | 31 Mar 2023 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.08%
|
177,243
|
$345,624 | — | 31 Mar 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.08%
|
169,509
|
$330,542 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.07%
|
155,085
|
$302,415 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.07%
|
148,587
|
$289,745 | — | 31 Mar 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.07%
|
137,915
|
$268,934 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.05%
|
100,700
|
$196,000 | — | 31 Mar 2023 | |
| CITIGROUP INC |
13F
|
Company |
0.04%
|
87,006
|
$169,662 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.04%
|
79,908
|
$155,821 | — | 31 Mar 2023 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.04%
|
79,000
|
$154,050 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.04%
|
78,333
|
$152,749 | — | 31 Mar 2023 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.04%
|
74,842
|
$145,000 | — | 31 Mar 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.03%
|
63,783
|
$124,377 | — | 31 Mar 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.03%
|
59,127
|
$116,000 | — | 31 Mar 2023 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
52,645
|
$102,658 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.02%
|
51,222
|
$99,883 | — | 31 Mar 2023 | |
| LMR Partners LLP |
13F
|
Company |
0.02%
|
50,767
|
$98,996 | — | 31 Mar 2023 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.02%
|
50,500
|
$98,475 | — | 31 Mar 2023 | |
| Y-Intercept (Hong Kong) Ltd |
13F
|
Company |
0.02%
|
40,064
|
$78,125 | — | 31 Mar 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.02%
|
33,333
|
$65,000 | — | 31 Mar 2023 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.01%
|
31,227
|
$60,893 | — | 31 Mar 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.01%
|
28,960
|
$57,000 | — | 31 Mar 2023 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.01%
|
28,994
|
$56,538 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.01%
|
27,539
|
$53,701 | — | 31 Mar 2023 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.01%
|
26,820
|
$52,000 | — | 31 Mar 2023 | |
| TELEMUS CAPITAL, LLC |
13F
|
Company |
0.01%
|
25,214
|
$49,167 | — | 31 Mar 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
24,553
|
$47,879 | — | 31 Mar 2023 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
0.01%
|
20,909
|
$40,773 | — | 31 Mar 2023 |
Institutional Holders of Savara Inc - Common Stock, par value $0.001 per share (SVRA) as of Q2 2023
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.